首页> 外文期刊>Mechanisms of Ageing and Development >Age-related alterations in mesenchymal stem cells related to shift in differentiation from osteogenic to adipogenic potential: Implication to age-associated bone diseases and defects
【24h】

Age-related alterations in mesenchymal stem cells related to shift in differentiation from osteogenic to adipogenic potential: Implication to age-associated bone diseases and defects

机译:间充质干细胞与年龄相关的变化与成骨潜能向成脂潜能的转变有关:对年龄相关的骨疾病和缺陷的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Mesenchymal stem cells (MSC) have attracted considerable attention in the fields of cell and gene therapy due to their intrinsic ability to differentiate into multiple lineages. The various therapeutic applications involving MSC require initial expansion and/or differentiation . in vitro prior to clinical use. However, serial passages of MSC in culture lead to decreased differentiation potential and stem cell characteristics, eventually inducing cellular aging which will limit the success of cell-based therapeutic interventions. Here we review the age-related changes that occur in MSC with a special focus on the shift of differentiation potential from osteogenic to adipogenic lineage during the MSC aging processes and how aging causes this preferential shift by oxidative stress and/or energy metabolism defect. Oxidative stress-related signals and some microRNAs affect the differentiation potential shift of MSC by directly targeting key regulatory factors such as Runx-2 or PPAR-γ, and energy metabolism pathway is involved as well. All information described here including transcription factors, microRNAs and FoxOs could be used towards development of treatment regimens for age-related bone diseases and related defects based on mutually exclusive lineage fate determination of MSC.
机译:间充质干细胞(MSC)由于其固有的分化为多种谱系的能力而在细胞和基因治疗领域引起了相当大的关注。涉及MSC的各种治疗应用需要初始扩展和/或分化。在临床使用之前在体外。然而,MSC在培养物中的连续传代导致分化潜能和干细胞特性降低,最终诱导细胞衰老,这将限制基于细胞的治疗干预的成功。在这里,我们回顾了MSC中发生的与年龄相关的变化,特别关注了MSC衰老过程中分化潜力从成骨谱系向成脂谱系的转变,以及衰老如何通过氧化应激和/或能量代谢缺陷导致这种优先转变。氧化应激相关信号和一些microRNA通过直接靶向关键调控因子(如Runx-2或PPAR-γ)影响MSC的分化潜能转移,并且还涉及能量代谢途径。此处描述的所有信息,包括转录因子,microRNA和FoxO,都可用于基于相互排斥的MSC命运确定的年龄相关性骨疾病和相关缺陷的治疗方案的开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号